Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023" report has been added to ResearchAndMarkets.com's offering.
The clinical trials data used for these analyses were extracted from the analyst's Clinical Trials Database. The data includes clinical trials with a start date between January 1, 2023 and December 31, 2023, which were captured in the database as of February 14, 2023.
The trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials.
Reasons to Buy
- Trends of 2023 trial landscape
- Comparison to 2022 trial landscape
- Can view top therapy areas, indications, geographies and sponsors for 2023 trials
- Designated focus on completed and terminated trials for 2023
Key Topics Covered:
- Executive Summary
- Introduction
- Global Clinical Trial Landscape in 2023
- Completed Trials in 2023
- Clinical Trial Terminations in 2023
- Key Findings
- Appendix
For more information about this report visit https://www.researchandmarkets.com/r/9t9o47
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
